John St. Cyr, MD, PhD and Linda M. Shecterle, PhD, International Experts in the Use of D-Ribose in Cardiovascular Disease and In
23 May 2011 - 10:30PM
Marketwired
NuVim, Inc. (PINKSHEETS: NUVM) a leading provider of nutritional
refrigerated and shelf stable ready to drink beverages and powder
mixes announced today that John St. Cyr, MD, PhD. and Linda M.
Shecterle, PhD will be instrumental in directing the final secret
formulation of the new NuVim Wellness/Weight Control product line.
Between them they have published over 60 documents relating to the
use of D-Ribose in cardiovascular disease and daily vitality since
the mid-1980s. D-Ribose will be added to the Wellness/Weight
Control formula which has been under qualitative research for the
last 90 days. With the addition of D-Ribose to the all natural
formula, NuVim Wellness/Weight Control products will provide
benefits which will include daily vitality, energy recovery, immune
enhancement, increase the absorption of minerals/vitamins from the
diet, consistent digestion, and muscle, bone, and now
cardiovascular health.
Both Dr. St. Cyr and Dr. Shecterle commented, "We are both
impressed with the work NuVim has done over the years in focusing
their efforts to improve the everyday quality of life of people who
desire and work to be healthy. Their efforts in attempting to
educate people in proper eating behavior, exercise and good
nutrition are commendable. We are pleased to now be a part of the
NuVim team and look forward to helping in the final reformulation
stage and promote the new Wellness/Weight Control product line. In
addition, we both will be communicating the NuVim health benefits
to the general public and the medical community. We also thank Dr.
Addis and Ruth Carey L.D. for their activities with NuVim to bring
this new NuVim product this far and look forward to working with
them in the final leg of this product launch."
NuVim CEO Rick Kundrat commented that "The new Wellness product
line has application to people of all walks of life including the
military personnel, young and old, male and female."
About Dr. John St. Cyr: A leading expert in the use of
Ribose in cardiovascular disease Dr. St. Cyr has been involved in
Ribose research since mid-1980. Trained as a pediatric
cardiovascular surgeon, Dr. St. Cyr has a strong background in
biochemistry and physiology. He has more than 175 publications and
has presented his research at both national and international
medical meetings. He received his M.Sc. in physiology, which was
followed by M.D. and PhD degrees from the University of Minnesota, where he studied
the effect of Ribose on ischemic hearts. Currently, his research
and consulting is in the state of Minnesota and lectures throughout
the US and Europe. Dr St. Cyr holds numerous patents relating to
nutritional supplement benefits.
About Dr. Linda Shecterle: Dr. Shecterle has
devoted years to researching the effects of D-Ribose in diseases and wellness promoting
effects ranging from cardiovascular disorders to professional
athletics. She has published over 20 documents on Ribose and over
120 total publications in her career and also an inventor on
numerous patents.
About NuVim's New Wellness/Weight Control
Product Line: NuVim® has been qualitatively testing a new ALL
NATURAL line of powder mixes which formula can also be used to
improve in the NuVim ready to drink smoothie line and teas and
lemonade. The Wellness/Weight Control product is foremost about
feeling alert from when you wake up in the morning until bed time
without the high sugar and caffeine. Through the additional
guidance of Dr. St. Cyr and Dr. Shecterle along with team members
Ruth Carey D.D.S., L.D. and Dr. Paul Addis, the Wellness/Weight
Control product currently being tested will be modified to include
D-Ribose and improved in other ways before introduction.
To learn more about NuVim® visit www.nuvim.com or call toll free
877-850-877
CONTACT: To learn more about NuVim® visit www.nuvim.com call
toll free 877-850-877
NuVim (PK) (USOTC:NUVM)
Historical Stock Chart
From Feb 2025 to Mar 2025
NuVim (PK) (USOTC:NUVM)
Historical Stock Chart
From Mar 2024 to Mar 2025